NCT04703049View on ClinicalTrials.gov

The Effect of Whole Blood Viscosity on Contrast-Induced Nephropathy Development in Patients Undergoing Percutaneous Coronary Intervention

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

November 30, 2017

Conditions
Percutaneous Coronary Intervention Patients
Interventions
OTHER

Blood Viscosity Testing

we calculated WBV using the formula \[(0.12 × hematocrit) + (0.17 × (total protein - 2.07)\]. We defined CIN as the absolute (≥0.5 mg/dl) or relative increase (≥25%) in serum creatinine 48-72 h after exposure to a contrast agent compared with baseline serum creatinine values.

Trial Locations (1)

16320

Bursa Yüksek İhtisas Hastanesi, Bursa

All Listed Sponsors
lead

Bursa Postgraduate Hospital

OTHER

NCT04703049 - The Effect of Whole Blood Viscosity on Contrast-Induced Nephropathy Development in Patients Undergoing Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter